Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,813.86% | -230.14% | 281.70% | 13.76% | -277.99% |
| Total Depreciation and Amortization | 1.36% | -16.78% | 105.36% | -26.67% | -2.91% |
| Total Amortization of Deferred Charges | 36.46% | -1.07% | 4.87% | -8.56% | 4.43% |
| Total Other Non-Cash Items | 402,841.88% | 104.18% | -141.80% | -67.72% | 98.85% |
| Change in Net Operating Assets | 26.86% | -105.67% | -453.29% | 261.73% | 104.02% |
| Cash from Operations | 179.23% | -122.19% | 125.66% | -44.35% | 156.42% |
| Capital Expenditure | 30.34% | 2.30% | 0.16% | 0.21% | -92.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.54% | -133.07% | 9.96% | 283.39% | 72.74% |
| Cash from Investing | 39.73% | -745.38% | 59.13% | 96.77% | -497.05% |
| Total Debt Issued | -76.29% | 53.67% | 62.39% | -62.93% | -84.13% |
| Total Debt Repaid | -4.22% | 61.84% | 3.85% | 54.12% | -499.63% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 79.12% | 18.07% | -1,424.56% | 99.66% | -1,504.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -581.00% | -- | -- | 100.00% | -- |
| Cash from Financing | -159.75% | 594.78% | 64.10% | 78.76% | -126.14% |
| Foreign Exchange rate Adjustments | 179.93% | 155.76% | -204.85% | 788.62% | 77.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -191.43% | -123.29% | 39,616.46% | 99.98% | -219.39% |